-
Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study
-
View Affiliations Hide AffiliationsS Jiménez-Jorgesjimenezj isciii.es
-
View Citation Hide Citation
Citation style for this article: . Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill. 2014;19(9):pii=20727. https://doi.org/10.2807/1560-7917.ES2014.19.9.20727 Received: 14 Feb 2014
Abstract
Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: ?9 to 62), 33% (95% CI: ?33 to 67) and 28% (95% CI: ?33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: ?11 to 72), 36% (95% CI: ?64 to 75) and 42% (95% CI: ?29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.
Full text loading...